The drop represents a return to a more normal pace of openings post-pandemic but likely also reflects the reimbursement and regulatory challenges facing the industry.

Quest will become the exclusive independent national laboratory provider of clinical lab and anatomic pathology services for Sentara members in Florida and Virginia.

Last week, readers were most interested in a story about how diagnostic firms may be impacted by the FDA's final rule on laboratory-developed tests.

Several firms are bringing high-sensitivity cardiac troponin testing into the ER, although doctors are not yet certain how ...

The firm will use the money to help advance the development of its digital slide image sharing platform, invest in personnel, and reach regulatory milestones.

The company said the parties had not met certain milestones required for commercialization of the test, which predicts risk of diabetic kidney disease.

GenomOncology's Pathology Workbench will be used as the clinical genomic reporting platform for Precipio's myeloid neoplasm test.

NEW YORK – The US Food and Drug Administration in August granted 510(k) marketing clearance for immunoassays for various infectious diseases, including Toxoplasma gondii infection, syphilis, ...

The firm said that it plans to use the money to help launch its diagnostics division, expand its testing menu, and hire a chief operating officer.

Rome-based Policlinico Gemelli will establish an in-house liquid biopsy testing service within its hospital system utilizing Guardant360 CDx.